| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C20H26N2 |
| Molar mass | 294.442 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Tetrindole was a drug candidate that functions byreversibly inhibitingmonoamine oxidase A; it was first synthesized in Moscow in the early 1990s.[1] Tetrindole is similar in its chemical structure topirlindole (Pyrazidol), andmetralindole.[2]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |